Resect, irradiate, or target first?
For stage III disease the answer turns on mediastinal nodes, a driver mutation and PD-L1. They sit on one screen beside the CT, already windowed for lung.
Live tumour board workspaceThoracic · Neuro · Breast · GI · Heme · Multi-Organ
OncoBoard MDT is where multidisciplinary tumour boards prepare, review and decide. The dossier is complete before the meeting. Every specialist reads the same slice during it. The signed recommendation is on file before the next case loads.
30 minutes, onlineYour boards and rolesDe-identified sample case
Why this exists
Researchers sat in on 96 lung cancer MDT meetings across eight teams in one UK cancer network. They found inefficiencies in every one of them.
of case discussions ended with the decision deferred, most often because results were still pending.
of meetings observed were fully quorate. Palliative care was the specialty most often missing.
of cases discussed had fitness or performance status information available, ranging from 30% to 75% by team.
Source: Zasada et al., Cancer Medicine, 2023. 8 lung MDTs, 96 meetings, 12 weeks.Read the studyNHS England streamlining guidance, 2020
NHS England's 2020 guidance asks teams to give full discussion to complex cases and manage the rest against agreed standards of care. That only works if each case arrives prepared and leaves recorded.
Organ Tumour Boards
Each board opens with the imaging window, staging and markers it actually argues about. Run one board or every board, on one record per case. Explore every board
For stage III disease the answer turns on mediastinal nodes, a driver mutation and PD-L1. They sit on one screen beside the CT, already windowed for lung.
Since WHO CNS5 in 2021, the molecular result is part of the diagnosis. Histology, IDH, 1p/19q and MGMT arrive together, so nobody decides on half a report.
Receptor status splits more ways than it used to. ER, PR, the HER2 score, Ki-67 and germline results sit next to the breast MRI before neoadjuvant or surgical options are weighed.
With liver metastases the surgeon asks first. The liver window, calibrated measurements, mismatch repair status and RAS/BRAF are on screen when the question comes.
Lymphoma boards read PET-CT against the Deauville scale. Leukaemia boards weigh ELN 2022 risk. Both get imaging, cytogenetics and molecular results in one dossier.
Unknown primary, oligometastatic disease and second primaries need every specialty at once. The Multi-Organ board brings every preset and every marker set to one agenda.
Workflow
Follow ONC-2026-4102, a 64-year-old with right upper lobe adenocarcinoma, through a Thoracic Board. Every panel below is interactive. See the full platform
The coordinator enters MRN, initials, board and urgency. TNM resolves to an AJCC stage group. Pathology, IHC, NGS and trial matches attach to the same case, so nothing is chased by email the night before.
The radiologist drives the study. Every connected clinician follows the same slice, window and measurement in real time. Target lesions are measured once, calibrated, and saved to the case.
Each specialty votes with its rationale. Quorum is met at three specialties and the whole room can see it. Dissent is kept with the case instead of disappearing with the meeting.
AI drafts the minutes from the votes and discussion. The chair edits, signs off and exports the consensus report for the EHR. Each step is written to the audit log with who and when.
Case. 64-year-old, right upper lobe adenocarcinoma, AJCC T2b N2 M0, Stage IIIA, ECOG 1. EGFR p.Leu858Arg, PD-L1 65% TPS.
Recommendation. Multistation N2, not for upfront resection. Concurrent chemoradiation, then osimertinib consolidation. Restage CT at 12 weeks.
Votes. 5 of 5 specialties in favour. No dissent recorded.
AI decision support. Review and edit before ratifying.
Roles
Six specialties come to a tumour board with six different jobs. OncoBoard gives each one the view it needs, on the same case.
AI Decision Support
Four assistants do the reading and writing a board never has time for. None of them can vote, sign off or change the record. How the AI works
A one-page brief of staging, pathology, molecular drivers and open questions, ready before the meeting starts.
A structured read of the current DICOM slice as a second look for the radiologist, never a replacement.
Minutes drafted from the votes and discussion for the chair to edit and sign.
Plain-language questions answered from the dossier in front of the board.
AI decision support. Verify against source records before use.
Clinical Analytics
Turnaround from intake to consensus, by board and by urgency, against your SLA. Export any view as CSV for the governance meeting. Analytics in detail
Hours from intake to Consensus Reached
Example data for illustration.
Security & governance
Your information governance team will ask these questions first. Here are the answers. Read the security overview
Cases carry an MRN and initials. The case record has no field for a full name, date of birth or address.
ONC-2026-4102 · R.K.
Passwords are salted per user, hashed with scrypt and compared in constant time.
scrypt · 16-byte salt · 64-byte key
Sessions expire after 12 hours and are revoked at sign-out.
256-bit random bearer token
Registrations, measurements, votes and sign-offs write to an audit log with who did what and when.
Audit & Database view for IT
Assistants draft and answer. Only a clinician can vote, ratify or edit the record.
Labelled · disclaimed · human sign-off
OncoBoard runs on Node.js and MySQL, so it can be deployed on infrastructure your governance team approves.
Node.js · MySQL · WebSocket sync
FAQ
A 30-minute session, online, with the people who sit on your board.